14 Jun, 2024 Event in Review: Why Can They Say That, but I Can’t? How to Challenge Your Competitors’ Advertising While Avoiding Being Targeted By Shahin Rothermel Claudia Lewis Losing market share to a competitor touting its superiority makes your job harder and is frustrating, particularly when those claims are...
03 Mar, 2024 Marketing FDA-Regulated Products: An Excerpt from the Advertising Law Tool Kit By Claudia Lewis Todd Harrison Join us over the next few months as we spotlight select chapters of Venable’s popular Advertising Law Tool Kit, which helps marketing...
28 Feb, 2024 Listen to Episode 2 of Venable’s Ad Law Tool Kit Show—“Marketing FDA-Regulated Products” By Shahin Rothermel Episode 2 of the Ad Law Tool Kit Show, “Marketing FDA-Regulated Products,” is now available. Listen here, or search for it in your...
02 Jan, 2024 FDA Issues New Rule and Guidance on DTC Prescription Drug TV and Radio Advertising By Jeff Greenbaum As 2023 came to a close, the U.S. Food and Drug Administration issued a new rule on direct-to-consumer prescription drug advertising...
05 Oct, 2021 New California CBD Law Highlights the Federal / State Regulatory Divide By Gary A. Kibel Louis DiLorenzo California’s newly passed Assembly Bill 45 now explicitly permits cannabidiol (CBD) to be included in food and dietary supplement...
29 Jan, 2020 FDA to Conduct Studies on the Effectiveness of Influencer and Other Endorser Disclosures By Jeff Greenbaum This week, the U.S. Food and Drug Administration announced that it is planning to conduct studies on the effectiveness of the disclosures...
03 Nov, 2019 FDA Puts Homeopathic Industry on Notice – No More Lax Enforcement By Len Gordon By Todd Harrison, Claudia Lewis, and Todd Halpern Agency Denies Industry Petition and Publishes Revised Draft Guidance The U.S. Food and...
28 Oct, 2019 A New Challenge for FDA? By Len Gordon By Todd Halpern Two Executive Orders Continue Trump Administration Efforts to Restrain Agency Policymaking Last week, President Trump...
23 Sep, 2019 Alzheimer’s and Cancer? FTC Announcement Shows That FDA Is Not the Only Agency That Is “Serious” By Len Gordon